Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3

Author: Lathers Deanne   Clark Joseph   Achille Nicholas   Young M.  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.53, Iss.5, 2004-05, pp. : 422-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content